8-K - Esperion Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Material Agreement

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. On October 7, 2025, Esperion Therapeutics, Inc. (the “Company”) entered into an Underwriting Agreement (the “Under

Material Agreement

$2.50$70.2M$80.7M

8.01

. Other Events. On October 7, 2025, the Company issued a press release announcing the Offering. On October 7, 2025, the Company issued a press release announcin

Other Event

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 1.1 Underwriting Agreement, dated as of October 7, 2025, by and among Esperion Therape

Exhibits Only

Source Document

Exhibits (5)

1.1

EXHIBIT 1.1

5.1

EXHIBIT 5.1

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2